肺动脉高压生活质量的评估和评价工具：使用 COSMIN 方法的系统回顾。

IF 3.5 3区医学 Q2 CARDIAC & CARDIOVASCULAR SYSTEMS

Respiratory medicine Pub Date : 2024-10-06 DOI:10.1016/j.rmed.2024.107829

Gangemi Irene , Cedrone Nadia , Lommi Marzia , Paolo Iovino , Vellone Ercole

{"title":"肺动脉高压生活质量的评估和评价工具：使用 COSMIN 方法的系统回顾。","authors":"Gangemi Irene , Cedrone Nadia , Lommi Marzia , Paolo Iovino , Vellone Ercole","doi":"10.1016/j.rmed.2024.107829","DOIUrl":null,"url":null,"abstract":"<div><h3>Aim</h3><div>The aim of this review was to identify specific instruments currently available for measuring quality of life in patients with pulmonary arterial hypertension (PAH) and to evaluate their psychometric properties in order to provide robust evidence for their application in clinical practice.</div></div><div><h3>Background</h3><div>Pulmonary arterial hypertension is a rare pulmonary vascular disorder predominantly affecting women aged 30–50 years. It leads to elevated pulmonary artery pressure, causing increased cardiac workload. Symptoms such as dyspnea and fatigue progressively deteriorate. Given the substantial impact on patient well-being, quality of life assessment is a critical concern. Generic quality of life measures often fail to capture the unique challenges associated with PAH. Therefore, identifying a PAH-specific quality of life instrument is essential for optimising patient management.</div></div><div><h3>Design</h3><div>A systematic literature review.</div></div><div><h3>Methods</h3><div>A systematic review was performed to assess the psychometric properties of quality of life instruments for PAH patients, following the 2018 Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. The literature search was conducted across Pubmed, Scopus, CINAHL, EMBASE, and APA PsycINFO databases.</div></div><div><h3>Results</h3><div>This review included four quality of life instruments: CAMPHOR, LPHQ, emPHasis-10, and PAH-SYMPACT. CAMPHOR and PAH-SYMPACT received a GRADE A rating, while LPHQ and emPHasis-10 were rated GRADE B. Despite some sample size limitations, these instruments demonstrated varying degrees of internal reliability, validity, and content coverage for assessing quality of life in pulmonary arterial hypertension patients.</div></div><div><h3>Conclusions</h3><div>This review provides an overview of available tools for assessing quality of life in patients with pulmonary arterial hypertension. Critical evaluation of these tools highlights incomplete psychometric assessments and methodological limitations in reference studies. Future research should prioritise more rigorous methodologies to ensure comprehensive psychometric evaluations.</div></div>","PeriodicalId":21057,"journal":{"name":"Respiratory medicine","volume":null,"pages":null},"PeriodicalIF":3.5000,"publicationDate":"2024-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Appraisal and evaluation of the quality of life in pulmonary arterial hypertension instruments: A systematic review using COSMIN methodology\",\"authors\":\"Gangemi Irene , Cedrone Nadia , Lommi Marzia , Paolo Iovino , Vellone Ercole\",\"doi\":\"10.1016/j.rmed.2024.107829\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Aim</h3><div>The aim of this review was to identify specific instruments currently available for measuring quality of life in patients with pulmonary arterial hypertension (PAH) and to evaluate their psychometric properties in order to provide robust evidence for their application in clinical practice.</div></div><div><h3>Background</h3><div>Pulmonary arterial hypertension is a rare pulmonary vascular disorder predominantly affecting women aged 30–50 years. It leads to elevated pulmonary artery pressure, causing increased cardiac workload. Symptoms such as dyspnea and fatigue progressively deteriorate. Given the substantial impact on patient well-being, quality of life assessment is a critical concern. Generic quality of life measures often fail to capture the unique challenges associated with PAH. Therefore, identifying a PAH-specific quality of life instrument is essential for optimising patient management.</div></div><div><h3>Design</h3><div>A systematic literature review.</div></div><div><h3>Methods</h3><div>A systematic review was performed to assess the psychometric properties of quality of life instruments for PAH patients, following the 2018 Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. The literature search was conducted across Pubmed, Scopus, CINAHL, EMBASE, and APA PsycINFO databases.</div></div><div><h3>Results</h3><div>This review included four quality of life instruments: CAMPHOR, LPHQ, emPHasis-10, and PAH-SYMPACT. CAMPHOR and PAH-SYMPACT received a GRADE A rating, while LPHQ and emPHasis-10 were rated GRADE B. Despite some sample size limitations, these instruments demonstrated varying degrees of internal reliability, validity, and content coverage for assessing quality of life in pulmonary arterial hypertension patients.</div></div><div><h3>Conclusions</h3><div>This review provides an overview of available tools for assessing quality of life in patients with pulmonary arterial hypertension. Critical evaluation of these tools highlights incomplete psychometric assessments and methodological limitations in reference studies. Future research should prioritise more rigorous methodologies to ensure comprehensive psychometric evaluations.</div></div>\",\"PeriodicalId\":21057,\"journal\":{\"name\":\"Respiratory medicine\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Respiratory medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0954611124003044\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiratory medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0954611124003044","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 0

摘要

目的：本综述旨在确定目前可用于测量肺动脉高压（PAH）患者生活质量的特定工具，并评估其心理测量特性，从而为其在临床实践中的应用提供有力证据：背景：肺动脉高压是一种罕见的肺血管疾病，主要影响 30-50 岁的女性。它导致肺动脉压力升高，增加了心脏的工作负荷。呼吸困难和疲劳等症状会逐渐恶化。鉴于对患者福祉的重大影响，生活质量评估是一个关键问题。通用的生活质量衡量标准往往无法捕捉到 PAH 所带来的独特挑战。因此，确定 PAH 专用的生活质量工具对于优化患者管理至关重要：设计：系统性文献综述：根据 2018 年基于共识的健康测量工具选择标准（COSMIN）指南，对 PAH 患者生活质量工具的心理测量特性进行了系统性回顾评估。文献检索在 Pubmed、Scopus、CINAHL、EMBASE 和 APA PsycINFO 数据库中进行：结果：本综述包括四种生活质量工具：CAMPHOR、LPHQ、emPHasis-10 和 PAH-SYMPACT。CAMPHOR和PAH-SYMPACT被评为A级，LPHQ和emPHasis-10被评为B级。尽管存在一些样本量的限制，但这些工具在评估肺动脉高压患者生活质量方面表现出了不同程度的内部可靠性、有效性和内容覆盖性：本综述概述了现有的肺动脉高压患者生活质量评估工具。对这些工具的严格评估强调了参考研究中不完整的心理计量评估和方法上的局限性。未来的研究应优先采用更严格的方法，以确保心理计量评估的全面性：在提交论文时，请在标题页上注明 TWEETABLE ABSTRACT：可选择附加 140 个字符的信息，并可 "推送"。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Appraisal and evaluation of the quality of life in pulmonary arterial hypertension instruments: A systematic review using COSMIN methodology

Aim

The aim of this review was to identify specific instruments currently available for measuring quality of life in patients with pulmonary arterial hypertension (PAH) and to evaluate their psychometric properties in order to provide robust evidence for their application in clinical practice.

Background

Pulmonary arterial hypertension is a rare pulmonary vascular disorder predominantly affecting women aged 30–50 years. It leads to elevated pulmonary artery pressure, causing increased cardiac workload. Symptoms such as dyspnea and fatigue progressively deteriorate. Given the substantial impact on patient well-being, quality of life assessment is a critical concern. Generic quality of life measures often fail to capture the unique challenges associated with PAH. Therefore, identifying a PAH-specific quality of life instrument is essential for optimising patient management.

Design

A systematic literature review.

Methods

A systematic review was performed to assess the psychometric properties of quality of life instruments for PAH patients, following the 2018 Consensus-based Standards for the Selection of Health Measurement Instruments (COSMIN) guidelines. The literature search was conducted across Pubmed, Scopus, CINAHL, EMBASE, and APA PsycINFO databases.

Results

This review included four quality of life instruments: CAMPHOR, LPHQ, emPHasis-10, and PAH-SYMPACT. CAMPHOR and PAH-SYMPACT received a GRADE A rating, while LPHQ and emPHasis-10 were rated GRADE B. Despite some sample size limitations, these instruments demonstrated varying degrees of internal reliability, validity, and content coverage for assessing quality of life in pulmonary arterial hypertension patients.

Conclusions

This review provides an overview of available tools for assessing quality of life in patients with pulmonary arterial hypertension. Critical evaluation of these tools highlights incomplete psychometric assessments and methodological limitations in reference studies. Future research should prioritise more rigorous methodologies to ensure comprehensive psychometric evaluations.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Respiratory medicine 医学-呼吸系统

CiteScore

7.50

自引率

0.00%

发文量

199

审稿时长

38 days

期刊介绍： Respiratory Medicine is an internationally-renowned journal devoted to the rapid publication of clinically-relevant respiratory medicine research. It combines cutting-edge original research with state-of-the-art reviews dealing with all aspects of respiratory diseases and therapeutic interventions. Topics include adult and paediatric medicine, epidemiology, immunology and cell biology, physiology, occupational disorders, and the role of allergens and pollutants. Respiratory Medicine is increasingly the journal of choice for publication of phased trial work, commenting on effectiveness, dosage and methods of action.